Fingerprint
Dive into the research topics where Maurice Wouters is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Impact of COVID-19 pandemic on treatment patterns for stage I Non-Small Cell Lung Cancer in the Netherlands
van Vuren, R. M. G., Wolfhagen, N., Damhuis, R. A. M., Kruijff, S., van der Plas, W. Y., Schreurs, W. H., Schuurbiers, O. C. J., Smit, H. J. M., Verhagen, A. F. T. M., Wouters, M. W., Belderbos, J. & Heineman, D. J., 1 Jan 2026, In: Cancer treatment and research communications. 46, 101061.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile20 Downloads (Pure) -
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
DePalo, D. K., Dugan, M. M., Naqvi, S. M. H., Ollila, D. W., Hieken, T. J., Block, M. S., van Houdt, W. J., Wouters, M. W. J. M., Reijers, S. J. M., Asher, N., Broman, K. K., Duncan, Z., Anderson, M., Gyorki, D. E., Snow, H., Held, J., Farma, J. M., Vetto, J. T., Hui, J. Y. C. & Kolbow, M. & 10 others, , 1 Jan 2025, In: Cancer. 131, 1, e35636.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure) -
Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis
Bloem, M., de Meza, M. M., van den Eertwegh, A. J. M., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, J. J., Boreel, C. D. M., de Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., Kapiteijn, E., van Not, O. J., Piersma, D., Rikhof, B., Stevense-den Boer, A. M., van der Veldt, A. A. M. & Vreugdenhil, G. & 2 others, , 29 Jun 2025, In: British journal of cancer. 132, 12, p. 1124-1130 7 p., 102290.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile32 Downloads (Pure) -
Clinical Features and Outcomes of Locally Advanced and Metastatic Basal Cell Carcinoma
Zwanenburg, A. A. J. H., van Houdt, W. J., Schrijver, A. M., Schreuder, W. H., Wouters, M. W. J. M. & Plasmeijer, E. I., 2 Oct 2025, In: Acta dermato-venereologica. 105, p. adv43240 adv43240.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile24 Downloads (Pure) -
Corrigendum to “Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry” [Eur. J. Cancer 212, 2024, 115056] (European Journal of Cancer (2024) 212, (S0959804924010220), (10.1016/j.ejca.2024.115056))
Özkan, A., Kapiteijn, E., van den Bos, F., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Bloem, M., Blokx, W. A. M., Boers-Sonderen, M. J., Bonenkamp, J. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Haanen, J. B., Holtslag, C. E., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Stevense-den Boer, A. M., Suijkerbuijk, K. P. M. & van der Veldt, A. A. M. & 4 others, , 5 Feb 2025, In: European Journal of Cancer. 216, 115194.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile27 Downloads (Pure)